Mirum Pharmaceuticals
Price & Volume
Stats
See moreOpen | $92.60 |
Previous Close | $93.33 |
Day Range | $91.57-$92.66 |
52W Range | $63.23-$130 |
Market Cap | $6.1B |
Shares Short | 6M |
Financials
See moreRevenue (12 Mos) | $670.7M |
Revenue Growth (YoY) | 39.6% |
Gross Profit (12 Mos) | $548.1M |
Diluted EPS | -$14.48 |
News
See moreYahoo Finance • 10 days ago
Here are the major earnings after the close Tuesday
Yahoo Finance • 2 months ago
Mirum Pharmaceuticals to Host Investor Call to Share Topline Results from the Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta on September 28, 2026
Yahoo Finance • 3 months ago
ProQR a new buy at BoA on RNA-editing platform
Yahoo Finance • 5 months ago
Mirum and Incyte's zilurgisertib shows positive Phase 2 data in FOP
About
CEO | Mr. Christopher Peetz |
Address | 989 East Hillsdale Boulevard, Foster City, CA, United States, 94404 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 470 |